PRESS RELEASE published on 07/19/2023 at 07:53, 3 years 2 months ago Biophytis Announces $3.8 Million Registered Direct Offering
PRESS RELEASE published on 07/18/2023 at 07:00, 3 years 2 months ago Biophytis and SEQENS sign a partnership to produce Sarconeos (BIO101) active compound
PRESS RELEASE published on 07/10/2023 at 07:00, 3 years 3 months ago Biophytis has filed with the FDA for authorization to initiate SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 06/19/2023 at 07:00, 3 years 3 months ago Biophytis reports clinical results for Sarconeos (BIO101) in sarcopenia treatment at the 16th SCWD International Congress
PRESS RELEASE published on 06/16/2023 at 23:00, 3 years 3 months ago Biophytis: RESULTS OF THE ANNUAL GENERAL MEETING ON JUNE 16, 2023 ALL RESOLUTIONS PRESENTED BY THE COMPANY HAVE BEEN ADOPTED
PRESS RELEASE published on 06/05/2023 at 08:00, 3 years 4 months ago Biophytis to participate at the BIO International Convention in Boston from the 5th to the 8th of June
PRESS RELEASE published on 05/26/2023 at 08:00, 3 years 4 months ago Biophytis has filed with the French National Authority for Health (HAS) an application for Early Access Authorisation (EAA) for Sarconeos (BIO101) in the treatment of severe forms of COVID-1
PRESS RELEASE published on 05/25/2023 at 08:00, 3 years 4 months ago Biophytis Presented Positive Results of Phase 2-3 COVA Study At The American Thoracic Society International Conference
PRESS RELEASE published on 05/15/2023 at 08:00, 3 years 4 months ago Biophytis has filed with the EMA for authorization to initiate SARA-31 phase 3 study in sarcopenia
PRESS RELEASE published on 05/11/2023 at 08:00, 3 years 5 months ago Successful capital increase for Biophytis with €2.3 million raised
Published on 10/12/2026 at 22:01, 46 minutes ago Fermi Announces Third Quarter 2026 Earnings Release and Call Date
Published on 10/12/2026 at 15:00, 7 hours 47 minutes ago Shelfie-Tech Announces Closing of Private Placement
Published on 10/12/2026 at 13:00, 9 hours 47 minutes ago U.S. Energy Secretary Chris Wright, EXIM Chairman John Jovanovic, Nebraska Governor Jim Pillen, Senators Deb Fischer and Pete Ricketts, and Congressman Adrian Smith to Visit NioCorp's Critical Minerals Mine Site
Published on 10/10/2026 at 04:45, 2 days 18 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 2 days 20 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/12/2026 at 20:30, 2 hours 17 minutes ago Correction of a release from 29.09.2026 18:15 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:30, 2 hours 17 minutes ago Correction of a release from 02.10.2026 14:59 CET/CEST - Multi Units Luxembourg: NOTICE TO THE SHAREHOLDERS
Published on 10/12/2026 at 20:05, 2 hours 42 minutes ago SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
Published on 10/12/2026 at 19:10, 3 hours 37 minutes ago Cell Impact announces acceleration of previously communicated order from US customer
Published on 10/12/2026 at 18:45, 4 hours 2 minutes ago Fraikin announces exclusive agreement with Asterion Industrial Partners to support its next phase of growth
Published on 10/12/2026 at 17:59, 4 hours 47 minutes ago Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 5 hours 2 minutes ago Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 6 hours 59 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026
Published on 10/12/2026 at 15:12, 7 hours 35 minutes ago Statement of transactions in own shares from October 5, 2026 to October 9, 2026
